{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:32:19Z","timestamp":1789014739269,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,26]]},"DOI":"10.7759\/cureus.22632","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T16:35:43Z","timestamp":1645893343000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Aplastic Anemia and Colon Cancer With Underlying Spliceosome Mutation: Is It an Incidental Finding or a Novel Association?"],"prefix":"10.7759","author":[{"given":"Aswani","family":"Thurlapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Boudreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinandan","family":"Guntupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzeem","family":"Bhayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010003","article-title":"The role of alternative splicing in the control of immune homeostasis and cellular differentiation","volume":"17","author":"Yabas M","year":"2016","unstructured":"Yabas M, Elliott H, Hoyne GF. The role of alternative splicing in the control of immune homeostasis and cellular differentiation. Int J Mol Sci. 2016, 17:10.3390\/ijms17010003","journal-title":"Int J Mol Sci"},{"key":"ref2","unstructured":"ZRSR2. (2010). Accessed. September 27, 2020: https:\/\/www.mycancergenome.org\/content\/gene\/zrsr2\/."},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-06-583260","article-title":"Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment","volume":"124","author":"Seidel MG","year":"2014","unstructured":"Seidel MG. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood. 2014, 124:2337-44.","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.SCI-19.SCI-19","article-title":"Clinical implications of spliceosome mutations: epidemiology, clonal hematopoiesis, and potential therapeutic strategies","volume":"128","author":"Walter MJ","year":"2016","unstructured":"Walter MJ, Graubert TA. Clinical implications of spliceosome mutations: epidemiology, clonal hematopoiesis, and potential therapeutic strategies. Blood. 2016, 128:","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13182","article-title":"Molecular pathogenesis of acquired aplastic anemia","volume":"102","author":"Boddu PC","year":"2019","unstructured":"Boddu PC, Kadia TM. Molecular pathogenesis of acquired aplastic anemia. Eur J Haematol. 2019, 102:103-10. 10.1111\/ejh.13182","journal-title":"Eur J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil E","year":"2013","unstructured":"Papaemmanuil E, Gerstung M, Malcovati L, et al.. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013, 122:3616-27. 10.1182\/blood-2013-08-518886","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang L","year":"2011","unstructured":"Wang L, Lawrence MS, Wan Y, et al.. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011, 365:2497-506. 10.1056\/NEJMoa1109016","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida K","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, et al.. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011, 478:64-9. 10.1038\/nature10496","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR project GENIE: powering precision medicine through an international consortium","volume":"7","author":"Andr\u00e9 F","year":"2017","unstructured":"Andr\u00e9 F, Arnedos M, Baras AS, et al.. AACR project GENIE: powering precision medicine through an international consortium. Cancer Discov. 2017, 7:818-31. 10.1158\/2159-8290.CD-17-0151","journal-title":"Cancer Discov"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku151","article-title":"Sudemycin E influences alternative splicing and changes chromatin modifications","volume":"42","author":"Convertini P","year":"2014","unstructured":"Convertini P, Shen M, Potter PM, et al.. Sudemycin E influences alternative splicing and changes chromatin modifications. Nucleic Acids Res. 2014, 42:4947-61. 10.1093\/nar\/gku151","journal-title":"Nucleic Acids Res"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler M","year":"2018","unstructured":"Seiler M, Yoshimi A, Darman R, et al.. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers. Nat Med. 2018, 24:497-504.","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.03.011","article-title":"Structural basis of splicing modulation by antitumor macrolide compounds","volume":"70","author":"Cretu C","year":"2018","unstructured":"Cretu C, Agrawal AA, Cook A, et al.. Structural basis of splicing modulation by antitumor macrolide compounds. Mol Cell. 2018, 70:265-73. 10.1016\/j.molcel.2018.03.011","journal-title":"Mol Cell"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1101\/gad.2014311","article-title":"Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A","volume":"25","author":"Corrionero A","year":"2011","unstructured":"Corrionero A, Mi\u00f1ana B, Valc\u00e1rcel J. Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes Dev. 2011, 25:445-59. 10.1101\/gad.2014311","journal-title":"Genes Dev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/75196-a-case-of-aplastic-anemia-and-colon-cancer-with-underlying-spliceosome-mutation-is-it-an-incidental-finding-or-a-novel-association","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:26Z","timestamp":1707507626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/75196-a-case-of-aplastic-anemia-and-colon-cancer-with-underlying-spliceosome-mutation-is-it-an-incidental-finding-or-a-novel-association"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.22632","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,26]]}}}